Segall Bryant & Hamill LLC significantly increased its stake in Boston Scientific Corporation (NYSE:BSX) by 155.9% in the third quarter, bringing their total holdings to $23.51 million. This move is part of broader institutional interest in Boston Scientific, with other investors also modifying their positions. Several Wall Street analysts maintain a “Buy” or “Strong Buy” rating for BSX, with a consensus target price of $108.36, despite a recent insider stock sale by CEO Michael F. Mahoney.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Segall Bryant & Hamill LLC Has $23.51 Million Position in Boston Scientific Corporation $BSX
Segall Bryant & Hamill LLC significantly increased its stake in Boston Scientific Corporation (NYSE:BSX) by 155.9% in the third quarter, bringing their total holdings to $23.51 million. This move is part of broader institutional interest in Boston Scientific, with other investors also modifying their positions. Several Wall Street analysts maintain a “Buy” or “Strong Buy” rating for BSX, with a consensus target price of $108.36, despite a recent insider stock sale by CEO Michael F. Mahoney.